Analgesics - Estonia | Statista Market Forecast

In Estonia, the revenue in the Analgesics market reached US$25.82m in 2024.
It is projected to experience an annual growth rate of 7.26% (CAGR 2024-2029).
When compared to other countries worldwide, the United States generates the highest revenue in this market, amounting to US$7.24bn in 2024.
In terms of per person revenues, in Estonia generates US$19.58 in 2024.
Estonia's growing demand for natural and herbal analgesics reflects the country's increasing focus on sustainable and alternative healthcare solutions.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Estonia has been experiencing steady growth in recent years, driven by several factors including customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in Estonia have played a significant role in shaping the development of the Analgesics market. Estonian consumers have shown a growing preference for over-the-counter (OTC) analgesics, which are easily accessible and do not require a prescription. This preference can be attributed to the convenience and affordability of OTC products, as well as the increasing awareness and self-care practices among consumers.Trends in the market have also contributed to the growth of the Analgesics market in Estonia. One notable trend is the rising demand for natural and herbal analgesics. Consumers are becoming more conscious of the ingredients in the products they use and are seeking alternatives to traditional pharmaceuticals. This trend aligns with the global shift towards natural and organic products, reflecting a growing interest in holistic health and wellness.Another trend in the Analgesics market in Estonia is the increasing popularity of online retail channels. With the rise of e-commerce, consumers have greater access to a wide range of products, including analgesics. Online platforms provide convenience and competitive pricing, attracting a growing number of consumers who prefer to shop from the comfort of their homes. This trend has led to the emergence of online pharmacies and the expansion of existing retail chains into the digital space.Local special circumstances also play a role in the development of the Analgesics market in Estonia. The country's aging population has contributed to the increased demand for analgesics. As the population ages, the prevalence of chronic pain conditions such as arthritis and back pain increases, driving the need for pain relief medications. Additionally, Estonia's healthcare system provides universal access to healthcare services, including pharmaceuticals, which further supports the demand for analgesics.Underlying macroeconomic factors have also influenced the growth of the Analgesics market in Estonia. The country's stable economic growth and increasing disposable income levels have contributed to higher consumer spending on healthcare products, including analgesics. As the economy continues to grow, consumers have more purchasing power, leading to increased demand for analgesics.In conclusion, the Analgesics market in Estonia is developing due to customer preferences for OTC products, trends in the market such as the demand for natural and herbal analgesics and the popularity of online retail channels, local special circumstances including an aging population and universal healthcare access, and underlying macroeconomic factors like stable economic growth and increasing disposable income levels. These factors collectively contribute to the growth and expansion of the Analgesics market in Estonia.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.